SEARCH

Current Edition

Building a better healthcare cluster
Volume 3 Issue 1

Building a better healthcare cluster

Science and technology have always been a powerful dynamic in regeneration, and the fourth industrial revolution has many parallels with the first in the way …

Continue Reading →
Unique Challenges and Opportunities in Orphan Diseases
Volume 3 Issue 1

Unique Challenges and Opportunities in Orphan Diseases

Looking back, the 1983 Orphan Drug Act was a pivotal moment for healthcare, not just in the US but worldwide too. Research on orphan diseases …

Continue Reading →
Geroscience and The Exposome
Volume 3 Issue 1

Geroscience and The Exposome

There has been an unprecedented shift in global demographics, as the human population becomes more aged. This is bringing with it a significant burden of …

Continue Reading →
Betting on the Bug, Part III_Leveraging the Microbiome to
Volume 3 Issue 1

Betting on the Bug, Part III: Leveraging the Microbiome to Generate New Models

Interest in the microbiome continues to grow at a robust rate, underlying its potential to significantly benefit human health. In part 1 of this series, …

Continue Reading →
Mass Spectrometry Supports Development of New
Volume 3 Issue 1

Mass Spectrometry Supports Development of New Oligonucleotide Therapeutics

Oligonucleotides’ ability to inhibit genes or to function as aptamers to interact with protein targets are increasingly vital research tools in the biopharmaceutical industry. Oligonucleotides …

Continue Reading →
Congenital Hyperinsulinism Treatment Gaps
Volume 3 Issue 1

Congenital Hyperinsulinism Treatment Gaps and a Potential Solution

Although rare diseases, by definition, affect fewer individuals than other diseases do, they tend to be particularly devastating: they are often debilitating or lethal. It …

Continue Reading →
Increasing Patient Access to Advanced Therapies
Volume 3 Issue 1

Increasing Patient Access to Advanced Therapies; the UK Perspective

Over the past five years, we have seen remarkable growth and clinical results in an area of medicine known as advanced therapy medicinal products (ATMPs), …

Continue Reading →
The New Drugs and Clinical Trial Rules of India
Volume 3 Issue 1

The New Drugs and Clinical Trial Rules of India: A Regulatory Highlights

The New Drugs and Clinical Trial Rules (NDTC), 2019 were recently issued, emphasising the changes on the regulatory aspects relating to clinical trials. The final …

Continue Reading →
Go-to-market Challenges of CAR-T Therapies
Volume 3 Issue 1

Go-to-market Challenges of CAR-T Therapies

CAR-T therapies are set to revolutionise cancer treatment. With first curative therapies gaining market access across the globe, CAR-T therapies are subject to numerous commercial …

Continue Reading →
Developing Plasmid DNA Production Platforms to
Volume 3 Issue 1

Developing Plasmid DNA Production Platforms to Support Novel Gene Therapies

Epilepsy is a debilitating illness which impacts the life of millions of people across the world. Tony Hitchcock of Cobra Biologics discusses how Cobra Biologics …

Continue Reading →
Driving the Commercialisation of Regenerative Medicine
Volume 3 Issue 1

Driving the Commercialisation of Regenerative Medicine

With more than 7000 distinct types of rare and genetic diseases and 400+ million individuals suffering from a rare disease, regenerative medicine holds the hope …

Continue Reading →
How the Biopharmaceutical Industry is Responding
Volume 3 Issue 1

How the Biopharmaceutical Industry is Responding to Patient Demand for Injection Alternatives

Biologics represent a powerful and innovative class of therapeutics in the fight against chronic disease and their sales are projected to reach $326 billion by …

Continue Reading →